HiJAKing SARS-CoV-2? The potential role of JAK inhibitors in the management of COVID-19
- PMID: 32385052
- DOI: 10.1126/sciimmunol.abc5367
HiJAKing SARS-CoV-2? The potential role of JAK inhibitors in the management of COVID-19
Abstract
JAK kinase inhibitors are being investigated as a way of managing cytokine storm in severe COVID-19 patients.
Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Worksce.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
